Osteopore Ltd (OSX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.739x

Based on the latest financial reports, Osteopore Ltd (OSX) has a cash flow conversion efficiency ratio of 0.739x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.28 Million ≈ $-903.25K USD) by net assets (AU$-1.73 Million ≈ $-1.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Osteopore Ltd (OSX) total market value for the company's overall valuation and market capitalisation.

Osteopore Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Osteopore Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Osteopore Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Osteopore Ltd ranked by their cash flow conversion efficiency. See Osteopore Ltd debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Future Supply Chain Solutions Limited NSE:FSC	0.108x
Usha Martin Education & Solutions Limited NSE:UMESLTD	0.019x
22nd Century Group Inc NASDAQ:XXII	0.174x
Margaret Lake Diamonds Inc V:DIA	0.054x
MT Educare Limited NSE:MTEDUCARE	-0.429x
EKF Diagnostics Holdings Plc LSE:EKF	0.068x
ProAm Explorations Corp V:PMX	0.370x
Golden Prospect Precious Metals Ltd LSE:GPM	-0.016x

Annual Cash Flow Conversion Efficiency for Osteopore Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Osteopore Ltd from 2016 to 2025. View Osteopore Ltd (OSX) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-1.73 Million ≈ $-1.22 Million	AU$-2.56 Million ≈ $-1.81 Million	1.481x	+114.69%
2024-12-31	AU$306.22K ≈ $216.67K	AU$-3.09 Million ≈ $-2.18 Million	-10.084x	-16.73%
2023-12-31	AU$432.60K ≈ $306.09K	AU$-3.74 Million ≈ $-2.64 Million	-8.639x	-355.31%
2022-12-31	AU$2.11 Million ≈ $1.49 Million	AU$-4.00 Million ≈ $-2.83 Million	-1.897x	-167.87%
2021-12-31	AU$5.37 Million ≈ $3.80 Million	AU$-3.81 Million ≈ $-2.69 Million	-0.708x	-262.52%
2020-12-31	AU$9.00 Million ≈ $6.37 Million	AU$-1.76 Million ≈ $-1.24 Million	-0.195x	+66.85%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-1.75 Million ≈ $-1.24 Million	-0.589x	-646.63%
2018-12-31	AU$4.23 Million ≈ $3.00 Million	AU$-334.12K ≈ $-236.41K	-0.079x	-1197.74%
2017-12-31	AU$-1.84 Million ≈ $-1.30 Million	AU$11.16K ≈ $7.90K	-0.006x	-104.48%
2016-12-31	AU$-1.36 Million ≈ $-959.71K	AU$-184.27K ≈ $-130.38K	0.136x	--

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies

Market Cap

$1.30 Million

AU$1.84 Million AUD

Market Cap Rank

#30504 Global

#1785 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.03

All Time High

AU$15.65